Back to mobile site

More on AQST

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+14.3% Growth)
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (11/9/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Aquestive Therapeutics Inc. (NQ:AQST)
Delayed: 4.61 -0.05 (1.07%)
Prev. Close $4.66  
Open$4.65 
52 Wk High$ 
52 Wk Low$ 
Day High$4.65 
Day Low$4.51 
P/E N/A  
EPS$ 
Volume3,509,337 

Friends, Peers and Foes (?): TLSA (more...)

Sep 17, 2026 07:03 AM Form 8-K Aquestive Therapeutics, For: Sep 14
Sep 17, 2026 07:00 AM Aquestive resubmits NDA to FDA for Anaphylm sublingual film
Sep 17, 2026 07:00 AM Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film
Sep 16, 2026 02:01 PM Form 4 Aquestive Therapeutics, For: Sep 15 Filed by: Barber Daniel
Sep 15, 2026 04:49 PM Form 144 Aquestive Therapeutics, Filed by: Barber Daniel
Sep 11, 2026 11:08 AM Form 4 Aquestive Therapeutics, For: Sep 09 Filed by: Korczynski Sherry
Sep 10, 2026 09:31 AM Cantor Fitzgerald Reiterates Overweight Rating on Aquestive Therapeutics (AQST)
Sep 10, 2026 09:22 AM Form 4 Aquestive Therapeutics, For: Sep 09 Filed by: Boyd Peter E.
Sep 1, 2026 07:00 AM Aquestive Therapeutics to Participate in Upcoming September Investor Conferences
Aug 18, 2026 04:13 PM Form 4 Aquestive Therapeutics, For: Aug 17 Filed by: Barber Daniel
View All Articles

Entities mentioned with AQST

View All Entities